Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

MEDPLUS HEALTH SERVICES 2023-24 Annual Report Analysis
Mon, 9 Sep

MEDPLUS HEALTH SERVICES has announced its results for the year ended March 2024. Let us have a look at the detailed performance review of the company during FY23-24.

MEDPLUS HEALTH SERVICES Income Statement Analysis

  • Operating income during the year rose 23.4% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 32.0% YoY during the fiscal. Operating profit margins witnessed a fall and down at 6.6% in FY24 as against 6.2% in FY23.
  • Depreciation charges increased by 23.5% and finance costs increased by 15.1% YoY, respectively.
  • Other income declined by 13.2% YoY.
  • Net profit for the year grew by 30.9% YoY.
  • Net profit margins during the year grew from 1.1% in FY23 to 1.2% in FY24.

MEDPLUS HEALTH SERVICES Income Statement 2023-24

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Net Sales Rs m 45,576 56,249 23.4%
Other income Rs m 461 400 -13.2%
Total Revenues Rs m 46,037 56,649 23.1%
Gross profit Rs m 2,814 3,713 32.0%
Depreciation Rs m 1,816 2,242 23.5%
Interest Rs m 987 1,136 15.1%
Profit before tax Rs m 472 734 55.7%
Tax Rs m -29 79 NA
Profit after tax Rs m 501 656 30.9%
Gross profit margin % 6.2 6.6
Effective tax rate % -6.2 10.7
Net profit margin % 1.1 1.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Don't Miss: Key Information for Long-term Investors

MEDPLUS HEALTH SERVICES Balance Sheet Analysis

  • The company's current liabilities during FY24 stood at Rs 5 billion as compared to Rs 5 billion in FY23, thereby witnessing an increase of 10.4%.
  • Current assets rose 6% and stood at Rs 16 billion, while fixed assets rose 7% and stood at Rs 14 billion in FY24.
  • Overall, the total assets and liabilities for FY24 stood at Rs 29 billion as against Rs 28 billion during FY23, thereby witnessing a growth of 6%.

MEDPLUS HEALTH SERVICES Balance Sheet as on March 2024

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Networth Rs m 14,607 15,476 5.9
 
Current Liabilities Rs m 4,766 5,259 10.4
Long-term Debt Rs m 0 0 0.0
Total Liabilities Rs m 27,645 29,430 6.5
 
Current assets Rs m 14,807 15,676 5.9
Fixed Assets Rs m 12,838 13,755 7.1
Total Assets Rs m 27,645 29,430 6.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



MEDPLUS HEALTH SERVICES Cash Flow Statement Analysis

  • MEDPLUS HEALTH SERVICES's cash flow from operating activities (CFO) during FY24 stood at Rs 1 billion, an improvement of 59.0% on a YoY basis.
  • Cash flow from investing activities (CFI) during FY24 stood at Rs -828 million on a YoY basis.
  • Cash flow from financial activities (CFF) during FY24 stood at Rs -2 billion on a YoY basis.
  • Overall, net cash flows for the company during FY24 stood at Rs -1 billion from the Rs 3 billion net cash flows seen during FY23.

MEDPLUS HEALTH SERVICES Cash Flow Statement 2023-24

Particulars No. of months 12 12 % Change
Year Ending Mar-23 Mar-24
Cash Flow from Operating Activities Rs m 904 1,437 59.0%
Cash Flow from Investing Activities Rs m 4,294 -828 -
Cash Flow from Financing Activities Rs m -1,702 -1,981 -
Net Cash Flow Rs m 3,496 -1,372 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for MEDPLUS HEALTH SERVICES

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 5.5, an improvement from the EPS of Rs 4.2 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 733.0, stands at 115.1 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 5.7 times, while the price to sales ratio stands at 1.6 times.
  • The company's price to cash flow (P/CF) ratio stood at 32.5 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Sales per share (Unadj.) Rs 382.0 470.5
TTM Earnings per share Rs 4.2 5.5
Diluted earnings per share Rs 4.2 5.5
Price to Cash Flow x 33.6 32.5
TTM P/E ratio x 155.4 115.1
Price / Book Value ratio x 6.6 6.1
Market Cap Rs m 96,459 94,159
Dividends per share (Unadj.) Rs 0.0 0.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for MEDPLUS HEALTH SERVICES

  • Solvency Ratios
  • Current Ratio: The company's current ratio deteriorated and stood at 3.0x during FY24, from 3.1x during FY23. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 1.6x during FY24, from 1.5x during FY23. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company improved and stood at 4.2% during FY24, from 3.4% during FY24. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 12.1% during FY24, from 10.0% during FY23. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company improved and stood at 6.1% during FY24, from 5.4% during FY23. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Current ratio x 3.1 3.0
Debtors’ Days Days 1 1
Interest coverage x 1.5 1.6
Debt to equity ratio x 0.0 0.0
Return on assets % 5.4 6.1
Return on equity % 3.4 4.2
Return on capital employed % 10.0 12.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how MEDPLUS HEALTH SERVICES has performed over the last 5 years, please visit here.

MEDPLUS HEALTH SERVICES Share Price Performance

Over the last one year, MEDPLUS HEALTH SERVICES share price has moved down from Rs 808.0 to Rs 733.0, registering a loss of Rs 75.0 or around 9.3%.

Overall, the S&P BSE SENSEX is up 23.3% over the year.

(To know more, check out historical annual results for MEDPLUS HEALTH SERVICES and quarterly results for MEDPLUS HEALTH SERVICES)

Annual Report FAQs

What is the current share price of MEDPLUS HEALTH SERVICES?

MEDPLUS HEALTH SERVICES currently trades at Rs 734.8 per share. You can check out the latest share price performance of MEDPLUS HEALTH SERVICES here...

What was the revenue of MEDPLUS HEALTH SERVICES in FY24? How does it compare to earlier years?

The revenues of MEDPLUS HEALTH SERVICES stood at Rs 56,649 m in FY24, which was up 23.1% compared to Rs 46,037 m reported in FY23.

MEDPLUS HEALTH SERVICES' revenue has grown from Rs 28,879 m in FY20 to Rs 56,649 m in FY24.

Over the past 5 years, the revenue of MEDPLUS HEALTH SERVICES has grown at a CAGR of 18.3%.

What was the net profit of MEDPLUS HEALTH SERVICES in FY24? How does it compare to earlier years?

The net profit of MEDPLUS HEALTH SERVICES stood at Rs 656 m in FY24, which was up 30.9% compared to Rs 501 m reported in FY23.

This compares to a net profit of Rs 947 m in FY22 and a net profit of Rs 631 m in FY21.

Over the past 5 years, MEDPLUS HEALTH SERVICES net profit has grown at a CAGR of 145.9%.

What does the cash flow statement of MEDPLUS HEALTH SERVICES reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of MEDPLUS HEALTH SERVICES reveals:

  • Cash flow from operations increased in FY24 and stood at Rs 1,437 m as compared to Rs 904 m in FY23.
  • Cash flow from investments decreased in FY24 and stood at Rs -828 m as compared to Rs 4,294 m in FY23.
  • Cash flow from financial activity decreased in FY24 and stood at Rs -1,981 m as compared to Rs -1,702 m in FY23.

Here's the cash flow statement of MEDPLUS HEALTH SERVICES for the past 5 years.

(Rs m)FY20FY21FY22FY23FY24
From Operations-66291,6999041,437
From Investments-276-345-7,0314,294-828
From Financial Activity898-564,404-1,702-1,981
Net Cashflow557-373-9283,496-1,372

What does the Key Ratio analysis of MEDPLUS HEALTH SERVICES reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of MEDPLUS HEALTH SERVICES reveals:

  • Operating profit margins witnessed a fall and down at 6.6% in FY24 as against 6.2% in FY23.
  • Net profit margins grew from 1.1% in FY23 to 1.2% in FY24.
  • Debt to Equity ratio for FY24 stood at 0.0 as compared to 0.0 in FY23.

Here's the ratio/financial analysis of MEDPLUS HEALTH SERVICES for the past 5 years.

 FY20FY21FY22FY23FY24
Operating Profit Margin (%)4.77.57.66.26.6
Net Profit Margin (%)0.12.12.51.11.2
Debt to Equity Ratio (x)0.00.00.00.00.0

 

Equitymaster requests your view! Post a comment on "MEDPLUS HEALTH SERVICES 2023-24 Annual Report Analysis". Click here!